Condition: Systemic Sclerosis · Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
The purpose of this study is to compare the efficacy and safety of BMS-986353 versus standard of care in participants with active Systemic Sclerosis
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 0035 | Scottsdale, Arizona, United States | — |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | — |
| Local Institution - 0001 | Denver, Colorado, United States | — |
| Local Institution - 0069 | Miami, Florida, United States | — |
| Emory University School of Medicine | Atlanta, Georgia, United States | — |
| Local Institution - 0139 | Chicago, Illinois, United States | — |
| Local Institution - 0084 | Worcester, Massachusetts, United States | — |
| Local Institution - 0034 | Ann Arbor, Michigan, United States | — |
| Local Institution - 0037 | Rochester, Minnesota, United States | — |
| Local Institution - 0082 | Summit, New Jersey, United States | — |
| Cleveland Clinic | Cleveland, Ohio, United States | — |
| Local Institution - 0142 | Philadelphia, Pennsylvania, United States | — |
+ 44 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.